Effect of combined treatment with carprofen and enalapril on ductus construction in dogs with patent ductus arteriosus

• Autorzy: Bakirel U , Gunes S. , Bakirel T.
• Języki publikacji: EN

Abstrakty

EN

The purpose of this study was to evaluate the effect of a combined treatment with carprofen and enalapril on ductus construction in the medical treatment of Golden retriever dogs with PDA which are unable to undergo surgical treatment and have delayed diagnosis. PDA was diagnosed by using Doppler, echocardiography, electrocardiography, X-ray, and blood analysis in 5 golden retrievers. Carprofen (2 mg/kg) and enalapril (0.5 mg/kg) were administered daily for 12 months and the dogs were controlled at 3 monthly intervals. Ductal construction was detected as 11% (p = ns) at the 3rd month, 24% (p < 0.05) at the 6th month, and 31% (p < 0.01) at the 9th month and 38% (p < 0.001) at the 1st year. An increase in the diameter of the main pulmonary artery was revealed after the 9th month (p < 0.05). No significant alteration was determined in the diameter of aorta, fractional shortening (FS %) and ejection fractioning (EF %) during the treatment. The results of the study indicated that the effect of a combined treatment of carprofen and enalapril is revealed after a long time period. Although a statistically significant decrease occurred in the diameter of the ductus, no complete closure in the ductus occurred. It was also detected that the severity of clinical signs in the dogs with PDA type-2, which had rendered them unacceptable for operation, was decreased by this medication.

Słowa kluczowe

EN

dog; animal disease; treatment; combined treatment; caprofen; enalapril; Golden retriever breed; patent ductus arteriosus; heart; ductus construction

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 11
• Opis fizyczny: p.1324-1327,fig.,ref.

Twórcy

autor

Bakirel U

• Istanbul University, Avcilar 34320, Turkey

autor

Gunes S.

autor

Bakirel T.

Bibliografia

• 1.Ackerman N., Burk R., Hahn A. W., Hayes H. M.: Patent Ductus arteriosus in the dogs: a retrospective study of radiographic, epidemiologic and clinical findings. Am. J. Vet. Res. 1978, 39, 1805-1810.
• 2.Atwel R. B.: Patent ductus arteriosus in a dog- attempted medical closure. Vet. Rec. 1977, 101, 425-426.
• 3.Birchard S. J., Bonagura J. D., Fingland R. B.: Result of ligation of patent ductus arteriosus: 201 cases (1969-1988) J. Am. Vet. Assoc. 1990, 196, 2011- -2013.
• 4.Brideau C., Staden C. V., Chan C. C.: In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats. Am. J. Vet. Res. 2001, 60, 1755- -1760.
• 5.Buchanan J. W., Buchler J. B.: Verterbral scala system to measure heart size in radiographs. J. Am. Vet. Assoc. 1995, 205, 194-199.
• 6.Buchanan J. W.: Prevalence of Cardiovascular Disorders, [in:] Fox P. R., Sisson D., Moise N. S. (Eds): Textbook of Canine and Feline Cardiology. Saunders W. B. Comp., Philadephia 1999, p. 457.
• 7.Buchanan J. W.: Patent ductus arteriosus: morphology, pathogenesis, types and treatment. J. Vet. Cardiol. 2001, 3, 7-16.
• 8.Chen K. Y.: Revaluation and revision of electrocardiography criteria for the diagnosis of left ventricular hypertrophy in dogs. J. Chinese. Vet. Sci. 1988, 14, 359-370.
• 9.Fox S. M., Johnston S. A.: Use of carprofen for the treatment of pain and inflammation in dogs. J. Am. Vet. Med. Assoc. 1997, 210, 1493-1498.
• 10.Goodwin J. K., Copper R. C., Weber W. J.: The medical management of pets with congenital heart defects. Vet. Med. 1992, 6, 670-675.
• 11.Goodwin J. K., Lombard C. W.: Patent Ductus Arteriosus in adult dogs: Clinical Features of 14 Cases. J. Am. Anim. Hosp. Assoc. 1992, 28, 349-353.
• 12.Grosfeld J. L., Kamman K, Gros K.: Comparative effects of indomethacin, prostaglandin E1 and ibuprofen on bowel ischemia. J. Ped. Surg. 1983, 18, 738-742.
• 13.Gutgesell H. P., Huhta L. C., Latson L. A., Huffines D., McNamara D. G.: Accuracy of two dimensional echocardiography in the diagnosis of congenital heart disease. Am. J. Cardiol. 1985, 55, 514-518.
• 14.Horng Su B., Tien Peng C., Hai Tsai C.: Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch. dis Child Fetal Neonetal 1999, 81, F197-200.
• 15.Hunt G. B., Church D. B., Malik R., Bellenger C. R.: A retrospective analysis of congenital cardiac anomalies (1977-1989). Aust. Vet. Pract. 1990, 20, 70-74.
• 16.Hunt G. B., Simpson D. J., Beck J. A., Goldsmid S. E., Lawrence D., Pearson M. R., Bellenger C. R.: Intraoperative haemorrhage during patent ductus arteriosus ligation in dogs. Vet. Surg. 2001, 30, 58-63.
• 17.Jones C. J., Budsberg S. C.: Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats. J.A.V.M.A. 2000, 217, 721- -729.
• 18.King A. S.: Foetal and neonatal circulation and respiration, [in:] The Cardiorespiratory System. Oxford, Blackwell Science Ltd. 1999, 391-414.
• 19.Kujubu D. A., Fletcher B. S., Varnum B. C.: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 1991, 266, 12866-12872.
• 20.Lonaas L., Nyman G., Palmer E.: Anti-inflammatory and analgesic treatment of osteoarthritis in the dog experiences from continuous treatment with carprofen. Svenks Veterinartidning. 1999, 51, 707-711.
• 21.Moise N. S.: Doppler echocardiographic evaluation of congenital heart disease. J. Vet. Int. Med. 1989, 3, 195-207.
• 22.Overmeire V. B.: The use of ibuprofen in neonates in the treatment of patent ductus arteriosus. IJCP supp. 2000, p. 135.
• 23.Patterson D. F.: Hereditary congenital heart defects in dogs. J. Small Anim. Pract. 1989, 30, 153-165.
• 24.Realkalli M. R., Hielm-Björkman A. K., Kejonen J., Salonen H. M., Sankari S. M.: Evalution of adverse effects of long-term orally administered carprofen in dogs. J.A.V.M.A. 2006, 228, 876-880.
• 25.Rickketts A. P., Lundy K. M., Seibel S. B.: Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am. J. Vet. Res. 1998, 59, 1441-1446.
• 26.Saunders J. H., Snaps F. R., Peeters D., Trotteur G., Dondelinger R. F.: Use of a balloon occlusion catheter to facilitate transarterial coil embolisation of a patent ductus arteriosus in two dogs. Vet. Rec. 1999, 6, 544-546.
• 27.Sisson D. D., Thomas W. T., Bonagura J. D.: Congenital Heart Disease, [in:] Ettinger S. J. (Ed): Textbook Of Veterinary Internal Medicine Disease Of The Dog And Cat. Saunders W. B. Comp. Philadelphia 2000, 745-750.
• 28.Suter P. F.: A text atlas of thoracic diseases of the dog and cat. Wettswil, Suter, Switzerland 1984, p. 1-45.
• 29.Tanaka R., Hoski K., Ngashima Y., Fuji Y., Yamane Y.: Detachable coils for occlusion of patent ductus arteriosus in 2 dogs. Vet. Surg. 2001, 30, 580-584.
• 30.Tilley L. P.: In Essential of canine and feline electrocardiography. Lea&Febiger, Philadelphia 1992, p. 60.
• 31.Türker R. K., Kayaalp O.: Rasyonel Tedavi Yönünden Týbbi Farmakoloji. Hacettepe-taº Comp., Ankara 2000, p. 1571.